APDN logo

Applied DNA Sciences (APDN) Operating Profit

Annual Operating Profit

-$14.02 M
-$3.07 M-28.04%

September 30, 2024

Summary

Performance

1-Year Change

-28.04%

3-Year Change

-11.96%

5-Year Change

-53.71%

15-Year Change

-9.4%

APDN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.45%
APDN annual operating income is higher than 61.45% of companies in Healthcare sector

High & Low

All-time High

-$600.00

3-Year Low

-$14.02 M
APDN annual operating income is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
APDN previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
APDN next annual earnings announcement has not yet been scheduled

OtherAPDNprofitabilitymetrics:

Annual Operating Margin

-408.72%
APDN annual operating profit margin is -408.72%

Annual Revenue

$3.43 M
APDN annual revenue is $3.43 million

Annual Net Income

-$6.99 M
APDN annual net profit is -$6.99 million

Annual EPS

-$1.82
APDN annual earnings per share is -$1.82

Quarterly Operating Profit

-$3.27 M
+$75.40 K+2.25%

September 1, 2024

Summary

Performance

3-Month Change

+2.25%

1-Year Change

+9.58%

3-Year Change

-20.98%

5-Year Change

-20.98%

APDN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.94%
APDN quarterly operating income is higher than 57.94% of companies in Healthcare sector

High & Low

All-time High

$0.00
APDN quarterly operating income is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$4.71 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
APDN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
APDN next earnings announcement is scheduled for Feb 13, 2025

OtherAPDNprofitabilitymetrics:

Quarterly Operating Margin

-402.32%
APDN quarterly operating profit margin is -402.32%

Quarterly Revenue

$813.10 K
APDN quarterly revenue is $813.10 thousand

Quarterly Net Income

-$3.30 M
APDN quarterly net profit is -$3.30 million

Quarterly EPS

-$0.32
APDN quarterly earnings per share is -$0.32

TTM Operating Profit

-$14.02 M
+$899.50 K+6.03%

September 1, 2024

Summary

Performance

3-Month Change

+6.03%

1-Year Change

+2.85%

3-Year Change

-27.13%

5-Year Change

-27.13%

APDN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.64%
APDN TTM operating income is higher than 59.64% of companies in Healthcare sector

High & Low

All-time High

-$200.00

3-Year Low

-$14.92 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
APDN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
APDN next earnings announcement is scheduled for Feb 13, 2025

OtherAPDNprofitabilitymetrics:

Annual Operating Margin

-408.72%
APDN annual operating profit margin is -408.72%

TTM Revenue

$3.43 M
APDN TTM revenue is $3.43 million

TTM Net Income

-$6.99 M
APDN TTM net profit is -$6.99 million

TTM EPS

-$6.96
APDN TTM earnings per share is -$6.96

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$14.02 M
APDN annual operating income is -$14.02 million

Annual Gross Profit

$1.02 M
APDN annual gross profit is $1.02 million

Annual Operating Expenses

$15.04 M
APDN annual total operating expenses is $15.04 million

APDN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.0%+9.6%+2.9%
3 y3 years-12.0%-21.0%-27.1%
5 y5 years-53.7%-21.0%-27.1%

APDN Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-28.0%at low-168.4%+30.5%-33.8%+6.0%
5 y5-year-53.7%at low-168.4%+30.5%-64.2%+6.0%
alltimeall time<-9999.0%+72.9%<-9999.0%+88.8%<-9999.0%+73.6%

Applied DNA Sciences Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-$14.02 M(+28.0%)
-
-
Sep 2024
-
-$3.27 M(-2.3%)
-$14.02 M(-6.0%)
Jun 2024
-
-$3.35 M(-7.5%)
-$14.92 M(+3.4%)
Mar 2024
-
-$3.62 M(-4.5%)
-$14.44 M(+6.8%)
Dec 2023
-
-$3.79 M(-9.2%)
-$13.52 M(+23.5%)
Sep 2023
-$10.95 M(-21.6%)
-$4.17 M(+45.9%)
-$10.95 M(-0.7%)
Jun 2023
-
-$2.86 M(+5.7%)
-$11.03 M(+0.0%)
Mar 2023
-
-$2.70 M(+121.8%)
-$11.03 M(+5.2%)
Dec 2022
-
-$1.22 M(-71.3%)
-$10.48 M(-25.0%)
Sep 2022
-$13.97 M(+11.5%)
-$4.25 M(+48.9%)
-$13.97 M(+3.9%)
Jun 2022
-
-$2.86 M(+32.6%)
-$13.45 M(-4.2%)
Mar 2022
-
-$2.15 M(-54.2%)
-$14.03 M(-1.1%)
Dec 2021
-
-$4.71 M(+26.1%)
-$14.20 M(+13.9%)
Sep 2021
-$12.53 M(-0.1%)
-$3.73 M(+8.4%)
-$12.46 M(-2.5%)
Jun 2021
-
-$3.44 M(+48.6%)
-$12.78 M(+2.0%)
Mar 2021
-
-$2.32 M(-22.1%)
-$12.53 M(-2.8%)
Dec 2020
-
-$2.97 M(-26.6%)
-$12.90 M(+2.9%)
Sep 2020
-$12.54 M(+37.4%)
-$4.05 M(+27.1%)
-$12.54 M(+21.2%)
Jun 2020
-
-$3.19 M(+18.9%)
-$10.35 M(+20.5%)
Mar 2020
-
-$2.68 M(+2.7%)
-$8.59 M(+0.6%)
Dec 2019
-
-$2.61 M(+40.1%)
-$8.54 M(-6.4%)
Sep 2019
-$9.12 M(-21.7%)
-$1.86 M(+30.2%)
-$9.12 M(-14.9%)
Jun 2019
-
-$1.43 M(-45.6%)
-$10.73 M(-11.8%)
Mar 2019
-
-$2.63 M(-17.6%)
-$12.16 M(+4.2%)
Dec 2018
-
-$3.20 M(-7.8%)
-$11.67 M(+0.2%)
Sep 2018
-$11.65 M(-9.2%)
-$3.47 M(+20.9%)
-$11.65 M(+5.6%)
Jun 2018
-
-$2.87 M(+34.0%)
-$11.02 M(+2.5%)
Mar 2018
-
-$2.14 M(-32.6%)
-$10.76 M(-10.6%)
Dec 2017
-
-$3.17 M(+11.7%)
-$12.04 M(-6.1%)
Sep 2017
-$12.82 M(+5.1%)
-$2.84 M(+9.2%)
-$12.82 M(+3.5%)
Jun 2017
-
-$2.60 M(-23.9%)
-$12.39 M(-6.2%)
Mar 2017
-
-$3.42 M(-13.4%)
-$13.21 M(-0.2%)
Dec 2016
-
-$3.95 M(+64.1%)
-$13.23 M(+8.5%)
Sep 2016
-$12.20 M(+55.3%)
-$2.41 M(-29.6%)
-$12.20 M(+18.7%)
Jun 2016
-
-$3.42 M(-0.7%)
-$10.28 M(+20.5%)
Mar 2016
-
-$3.45 M(+18.0%)
-$8.53 M(+22.5%)
Dec 2015
-
-$2.92 M(+498.6%)
-$6.96 M(-11.4%)
Sep 2015
-$7.85 M(-36.0%)
-$487.90 K(-70.8%)
-$7.86 M(-23.1%)
Jun 2015
-
-$1.67 M(-11.0%)
-$10.21 M(-7.4%)
Mar 2015
-
-$1.88 M(-50.8%)
-$11.03 M(-10.2%)
Dec 2014
-
-$3.82 M(+34.3%)
-$12.27 M(+0.0%)
Sep 2014
-$12.27 M(+20.6%)
-$2.84 M(+14.3%)
-$12.27 M(+4.2%)
Jun 2014
-
-$2.49 M(-20.5%)
-$11.78 M(-2.9%)
Mar 2014
-
-$3.13 M(-18.0%)
-$12.14 M(+4.5%)
Dec 2013
-
-$3.81 M(+62.1%)
-$11.62 M(+14.2%)
Sep 2013
-$10.18 M(+56.4%)
-$2.35 M(-17.3%)
-$10.18 M(+6.1%)
Jun 2013
-
-$2.84 M(+9.0%)
-$9.59 M(+17.3%)
Mar 2013
-
-$2.61 M(+9.9%)
-$8.17 M(+15.7%)
Dec 2012
-
-$2.37 M(+34.3%)
-$7.07 M(+8.6%)
Sep 2012
-$6.51 M
-$1.77 M(+23.8%)
-$6.51 M(-23.6%)
Jun 2012
-
-$1.43 M(-4.9%)
-$8.52 M(-0.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$1.50 M(-17.2%)
-$8.58 M(-1.9%)
Dec 2011
-
-$1.81 M(-52.0%)
-$8.74 M(+8.5%)
Sep 2011
-$8.06 M(+13.2%)
-$3.78 M(+153.3%)
-$8.06 M(+31.2%)
Jun 2011
-
-$1.49 M(-10.4%)
-$6.14 M(-13.8%)
Mar 2011
-
-$1.66 M(+47.9%)
-$7.12 M(+6.9%)
Dec 2010
-
-$1.12 M(-39.5%)
-$6.66 M(-6.4%)
Sep 2010
-$7.12 M(+3.2%)
-$1.86 M(-24.7%)
-$7.12 M(+10.3%)
Jun 2010
-
-$2.47 M(+105.4%)
-$6.45 M(+27.1%)
Mar 2010
-
-$1.20 M(-24.0%)
-$5.08 M(-10.1%)
Dec 2009
-
-$1.58 M(+32.6%)
-$5.65 M(-18.1%)
Sep 2009
-$6.90 M(+65.9%)
-$1.19 M(+8.9%)
-$6.90 M(+5.9%)
Jun 2009
-
-$1.10 M(-38.2%)
-$6.51 M(+3.4%)
Mar 2009
-
-$1.77 M(-37.4%)
-$6.30 M(+20.2%)
Dec 2008
-
-$2.83 M(+248.8%)
-$5.24 M(+26.1%)
Sep 2008
-$4.16 M(-66.9%)
-$812.20 K(-7.6%)
-$4.16 M(-56.0%)
Jun 2008
-
-$879.00 K(+22.5%)
-$9.45 M(-11.5%)
Mar 2008
-
-$717.30 K(-58.9%)
-$10.68 M(-11.7%)
Dec 2007
-
-$1.75 M(-71.4%)
-$12.10 M(-3.5%)
Sep 2007
-$12.54 M(-20.1%)
-$6.11 M(+190.6%)
-$12.54 M(-24.7%)
Jun 2007
-
-$2.10 M(-1.6%)
-$16.65 M(+1.1%)
Mar 2007
-
-$2.14 M(-2.5%)
-$16.46 M(+4.9%)
Dec 2006
-
-$2.19 M(-78.6%)
-$15.69 M(-0.1%)
Sep 2006
-$15.71 M(-69.6%)
-$10.22 M(+433.9%)
-$15.71 M(-54.7%)
Jun 2006
-
-$1.91 M(+40.1%)
-$34.64 M(-2.5%)
Mar 2006
-
-$1.37 M(-38.0%)
-$35.53 M(-20.3%)
Dec 2005
-
-$2.20 M(-92.4%)
-$44.58 M(-16.2%)
Sep 2005
-$51.71 M(+194.1%)
-$29.16 M(+938.8%)
-$53.17 M(+73.7%)
Jun 2005
-
-$2.81 M(-73.0%)
-$30.61 M(+3.8%)
Mar 2005
-
-$10.41 M(-3.6%)
-$29.48 M(+40.5%)
Dec 2004
-
-$10.80 M(+63.8%)
-$20.97 M(+19.3%)
Sep 2004
-$17.58 M(+407.0%)
-$6.59 M(+294.1%)
-$17.58 M(+14.3%)
Jun 2004
-
-$1.67 M(-12.4%)
-$15.38 M(+9.6%)
Mar 2004
-
-$1.91 M(-74.2%)
-$14.03 M(+11.8%)
Dec 2003
-
-$7.41 M(+68.7%)
-$12.56 M(+137.1%)
Sep 2003
-$3.47 M(>+9900.0%)
-$4.39 M(+1247.4%)
-$5.30 M(+484.6%)
Jun 2003
-
-$325.90 K(-24.7%)
-$906.10 K(+56.2%)
Mar 2003
-
-$433.00 K(+194.2%)
-$580.20 K(+294.2%)
Dec 2002
-
-$147.20 K(>+9900.0%)
-$147.20 K(+1611.6%)
Dec 2001
-$8600.00(+1128.6%)
-$200.00(-97.6%)
-$8600.00(0.0%)
Sep 2001
-
-$8200.00(+8100.0%)
-$8600.00(+1333.3%)
Jun 2001
-
-$100.00(0.0%)
-$600.00(-14.3%)
Mar 2001
-
-$100.00(-50.0%)
-$700.00(-12.5%)
Dec 2000
-$700.00(-79.4%)
-$200.00(0.0%)
-$800.00(-77.8%)
Sep 2000
-
-$200.00(0.0%)
-$3600.00(+5.9%)
Jun 2000
-
-$200.00(0.0%)
-$3400.00(0.0%)
Mar 2000
-
-$200.00(-93.3%)
-$3400.00(0.0%)
Dec 1999
-$3400.00(+112.5%)
-$3000.00(<-9900.0%)
-$3400.00(+750.0%)
Sep 1999
-
$0.00(-100.0%)
-$400.00(0.0%)
Jun 1999
-
-$200.00(0.0%)
-$400.00(+100.0%)
Mar 1999
-
-$200.00
-$200.00
Dec 1998
-$1600.00(+166.7%)
-
-
Dec 1997
-$600.00
-
-

FAQ

  • What is Applied DNA Sciences annual operating income?
  • What is the all time high annual operating profit for Applied DNA Sciences?
  • What is Applied DNA Sciences annual operating profit year-on-year change?
  • What is Applied DNA Sciences quarterly operating income?
  • What is the all time high quarterly operating profit for Applied DNA Sciences?
  • What is Applied DNA Sciences quarterly operating profit year-on-year change?
  • What is Applied DNA Sciences TTM operating income?
  • What is the all time high TTM operating profit for Applied DNA Sciences?
  • What is Applied DNA Sciences TTM operating profit year-on-year change?

What is Applied DNA Sciences annual operating income?

The current annual operating profit of APDN is -$14.02 M

What is the all time high annual operating profit for Applied DNA Sciences?

Applied DNA Sciences all-time high annual operating income is -$600.00

What is Applied DNA Sciences annual operating profit year-on-year change?

Over the past year, APDN annual operating income has changed by -$3.07 M (-28.04%)

What is Applied DNA Sciences quarterly operating income?

The current quarterly operating profit of APDN is -$3.27 M

What is the all time high quarterly operating profit for Applied DNA Sciences?

Applied DNA Sciences all-time high quarterly operating income is $0.00

What is Applied DNA Sciences quarterly operating profit year-on-year change?

Over the past year, APDN quarterly operating income has changed by +$346.50 K (+9.58%)

What is Applied DNA Sciences TTM operating income?

The current TTM operating profit of APDN is -$14.02 M

What is the all time high TTM operating profit for Applied DNA Sciences?

Applied DNA Sciences all-time high TTM operating income is -$200.00

What is Applied DNA Sciences TTM operating profit year-on-year change?

Over the past year, APDN TTM operating income has changed by +$411.90 K (+2.85%)